Results 31 to 40 of about 98,906 (300)

Multiple Immune Abnormalities in a Patient with Idiopathic CD4+ T-Lymphocytopenia [PDF]

, 2009
Idiopathic CD4+ T-lymphocytopenia (ICL) is a new disease entity characterized by CD4+ T-lymphocyte depletion without evidence of HIV infection. We report a 27-year-old ICL patient with a long history of multiple immune abnormalities.
Tsukasaki, Kunihiro, Hiroyuki Moriuchi, Masahiko Okada, Masanori Yanai, Kamitamari, Akira, Kamihira, Shimeru, Yasuaki Yamada, Hiroo Hasegawa, Hasegawa, Hiroo, Akira Kamitamari, Yamada, Yasuaki, Yanagihara, Katsunori, Kazuto Tsuruda, Kunihiro Tsukasaki, Katsunori Yanagihara, Osamu Hano, Okada, Masahiko, Shimeru Kamihira, Yanai, Masanori, Hano, Osamu, Moriuchi, Hiroyuki, Tsuruda, Kazuto   +21 more
core   +1 more source

Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda [PDF]

, 2004
Introduction: Total Lymphocyte Count (TLC) has been found to be an inexpensive and useful marker for staging disease, predicting progression to AIDS and death and monitoring response to ART.
Quinn, Thomas C, Nyama-Meya, Denise, Katabira, Elly T, Mayanja-Kizza, Harriet, Kamya, Moses R, Ronald, Allan, Spacek, Lisa A, Semitala, Fred C   +7 more
core   +4 more sources

CD4 and total lymphocyte counts as predictors of HIV disease progression [PDF]

QJM, 1996
CD4+ T-lymphocyte (CD4) counts are a standard laboratory marker of disease progression in HIV infection, but expense precludes their use in large parts of the world. Total lymphocyte counts (TLC), in contrast, are widely available. We compared CD4 and TLC counts as predictors of developing AIDS or death in 831 HIV-positive out-patients (582 males and ...
Post, Frank, Wood, R, Maartens, G
openaire   +3 more sources

Absolute Lymphocyte Count; the most Sensitive Indicator of the Risk of Progression and Complications in COVID-19

Pakistan Armed Forces Medical Journal, 2023
Objective: To explore the role of lymphocyte count as a predictor of severity biomarkers in COVID-19 patients. Study Design: Comparative cross-sectional study.
Kamran Ali, Khurram Haq Nawaz, Wahaj Ul Hassan, Raja Muhammad Waqar   +3 more
doaj   +1 more source

Clinico-Immunological Status and Neurocognitive Function of Perinatally Acquired HIV-Positive Children on cART: A Cross-Sectional Correlational Study in South Africa

Frontiers in Neurology, 2020
Despite the undisputed benefits of combination antiretroviral therapy (cART), perinatally acquired human immunodeficiency virus (PHIV) children on treatment often present with a spectrum of neurological deficits known as HIV-associated neurocognitive ...
Antonio G. Lentoor
doaj   +1 more source

Capillary blood as an alternative specimen for enumeration of percentages of lymphocyte subsets

BMC Research Notes, 2019
Objective Capillary blood has been increasingly used in point-of-care setting for clinical monitoring in immunology and infectious diseases. We explored whether percentages of lymphocyte subsets (T-cells; CD3+, helper T-cells; CD4+, cytotoxic T-cells ...
Supanart Srisala, Nutkridta Pongsakul, Thiantip Sahakijpicharn, Suradej Hongeng, Somchai Chutipongtanate, Nopporn Apiwattanakul   +5 more
doaj   +1 more source

Changes in Early T-Cell Subsets and Their Impact on Prognosis in Patients with Sepsis: A Single-Center Retrospective Study

International Journal of Clinical Practice, 2023
Objective. To analyze the early changes in CD3+, CD4+, and CD8+T-cell subset counts in patients with sepsis and their correlation with prognosis to provide a feasible basis for clinical immunomodulation in sepsis. Methods.
Yanhua Li, Youquan Wang, Bin Chen, Jianxing Guo, Dong Zhang   +4 more
doaj   +1 more source

Response to First-Line Antiretroviral Therapy Among PLHIV from a High-Risk, Low-Prevalence Setting

Journal of the International Association of Providers of AIDS Care, 2019
The study reports the response of first-line antiretroviral therapy (ART) by assessing CD4 and CD8 T-lymphocyte and viral load (VL) among Bangladeshi people living with HIV (PLHIV).
Shahria Mohammad Rashed Ul Islam M. Phil, MPH, Munira Jahan MD, Afzalun Nessa M. Phil, Shahina Tabassum M. Phil, PhD   +3 more
doaj   +1 more source

Baseline CD4 count and the time interval between the initial HIV infection and diagnosis among PLHIV in Bhutan

Immunity, Inflammation and Disease, 2021
Introduction CD4 count is an important predictor of disease progression, opportunities infection, deaths, and to understand the time interval between initial HIV infection to the first diagnosis.
Lekey khandu, Guru P. Dhakal, Karma Lhazeen   +2 more
doaj   +1 more source

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe [PDF]

, 2012
BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.
Amurwon, Jovita, Abdel G. Babiker (158530), Darbyshire Janet, Antonieta Medina Lara (168787), Antonieta Medina Lara, Charles F. Gilks (164480), Munderi Paula, Wakaholi, Barbara Nyanzi, Walker, A Sarah, Babiker, AG, Elly Katabira, Paula Munderi, Reid Andrew, Kasirye, Ronnie, James Hakim, Andrew Reid, Gibb, Diana M., Janet Darbyshire (59117), Jesse Kigozi (168794), Katabira Elly, Gilks, CF, Gilks, Charles F, Kityo Cissy, Darbyshire, J, Jovita Amurwon, Cissy Kityo, Walker A. Sarah, Kigozi, Jesse, Mugyenyi Peter, Barbara Nyanzi Wakaholi, Gibb, DM, Mugyenyi, Peter, Lara, AM, Walker, AS, Muchabaiwa Lazarus, Reid, Andrew, Peter Mugyenyi (168847), Darbyshire, Janet, Diana M. Gibb (164420), Medina Lara Antonieta, Ssali Francis, Kityo, Cissy, Grosskurth Heiner, Grosskurth, Heiner, Abdel G Babiker, Ruben E. Mujica Mota (168817), Kasirye Ronnie, Nyanzi Wakaholi, B, Jesse Kigozi, Walker, Ann, Wakaholi, BN, Team, Ssali, Francis, Ssali, F, Lazarus Muchabaiwa, Medina Lara, Antonieta, Hakim James, Walker, A. Sarah, Peter Mugyenyi, Janet Darbyshire, Gilks, Charles F., Team, DARTT, DART Trial Team, Diana M Gibb, Muchabaiwa, L, Elly Katabira (10701), A Sarah Walker, Kasirye, R, Ronnie Kasirye (168825), Paula Munderi (164469), Katabira, Elly, Muchabaiwa, Lazarus, Munderi, P, Hakim, J, Gibb, Diana M, Barbara Nyanzi Wakaholi (168811), Mota, Ruben E. Mujica, Gilks Charles F., Amurwon Jovita, Jovita Amurwon (168800), James Hakim (164478), Babiker, Abdel G, Amurwon, J, Charles F Gilks, Kityo, C, Nyanzi Wakaholi, Barbara, Babiker, Abdel G., Gibb Diana M., Mota, REM, Cissy Kityo (168842), Mujica Mota, Ruben E, Heiner Grosskurth (37057), Ruben E Mujica Mota, Reid, A, Medina-Lara, A, Kigozi Jesse, Francis Ssali, Mujica Mota Ruben E., Andrew Reid (168831), A. Sarah Walker (145609), Heiner Grosskurth, Lara, Antonieta Medina, Katabira, E, Ronnie Kasirye, Munderi, Paula, Grosskurth, H, Hakim, James, Francis Ssali (158549), Mujica-Mota, Ruben, Lazarus Muchabaiwa (168805), Kigozi, J, Mugyenyi, P, Nyanzi Wakaholi Barbara, Babiker Abdel G.   +113 more
core   +1 more source